Q: Is it at an attractive level to add to in order to get to a full position?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello 5i team
Is it a good idea to complete a position on WELL today?
Thanks
Is it a good idea to complete a position on WELL today?
Thanks
Q: Hi 5i,
I've owned DHT.UN in the past and did quite well - all before that little management fiasco. I sense the company may have completed a turnaround and be coming out of the penalty box now. I'm considering (re)adding it to my TFSA.
To help with the decision I'd appreciate your analysis of the quarter and year end results that were just released, along with any other comment you might have.
Thanks 5i,
Peter
I've owned DHT.UN in the past and did quite well - all before that little management fiasco. I sense the company may have completed a turnaround and be coming out of the penalty box now. I'm considering (re)adding it to my TFSA.
To help with the decision I'd appreciate your analysis of the quarter and year end results that were just released, along with any other comment you might have.
Thanks 5i,
Peter
Q: Hi 5i, thoughts on quarter and your views going forward? Not much commentary on tarrifs, although today's "tarrif goal posts" now will possibly omit compliant USMCA companies. Thx.
Q: These 2 stocks are health care and considered defensive. At what price for these two stocks would you consider a good price to buy?......Tom
Q: Could you comment on the Q here for Savaria. Would you be comfortable purchasing here?
-
Harvest Healthcare Leaders Income ETF (HHL $7.60)
-
Evolve Global Healthcare Enhanced Yield Fund (LIFE $19.47)
Q: I'm looking to invest in the healthcare sector for income and am considering HHL or LIFE. Which one would you recommend and why?
Q: hi folks...opinion on Q4/FY results for trans medic tmdx/q....seem pretty good and shoots down the short report from while ago....would you rate buy/hold/sell....thanks, jb
Q: Please comment on earnings and guidance for these 2 companies. Thank you.
Q: Could I get your take away points from the Q 4 release?
Q: Hi 5i
How were TEM earning and where do you see it going from here? Market does not seem to like.....Would 5I be interested after the 15% drop today? if so at what price
thx
How were TEM earning and where do you see it going from here? Market does not seem to like.....Would 5I be interested after the 15% drop today? if so at what price
thx
Q: Hi Peter, I was wondering why WELL was down over 5% today. Is there any news. Can you comment also on how the business is doing and would you add current pricing.
Thanks
Thanks
-
Biogen Inc. (BIIB $159.56)
-
Abbott Laboratories (ABT $127.00)
-
Eli Lilly and Company (LLY $988.62)
-
Pfizer Inc. (PFE $25.51)
-
Novo Nordisk A/S (NVO $49.15)
Q: November 2020 was your last response on the business fundamentals of this company. Recognizing that the stock price has dropped even more since then, what has changed with this company's outlook when comparing time periods?
How is its balance sheet and drug pipeline compared to Pfizer?
Pfizer is clearly more of an income play but that aside, do you favour one or the other for any particular reason?
How is its balance sheet and drug pipeline compared to Pfizer?
Pfizer is clearly more of an income play but that aside, do you favour one or the other for any particular reason?
Q: Have you heard of microcap nurs.v ? If so what do you think about their growth plans?
Q: Hi 5i Team,
May I please have your comments on this company given the negative news relating to it that occurred a few months ago. Would it be a hold, buy or sell now? If it is a "sell", please recommend a company or companies to take its place.
Cheers,
H
May I please have your comments on this company given the negative news relating to it that occurred a few months ago. Would it be a hold, buy or sell now? If it is a "sell", please recommend a company or companies to take its place.
Cheers,
H
Q: Wondering if you think this is a good opportunity to purchase ZTS as the clear industry leader in the animal health space after missing quarterly estimates. Or is the business in decline? Is PAHC the better buy right now based on valuations and growth going forward?
Q: ALT: US What is your impression on this clinical stage bio pharmaceutical company ?
Do these small bio pharma companies have any chance of being a take out target from the larger player?
What is your risk assessment on this company
From 1-10 . 1 being high risk . 10 being low risk.
Thanks
Cal .
Do these small bio pharma companies have any chance of being a take out target from the larger player?
What is your risk assessment on this company
From 1-10 . 1 being high risk . 10 being low risk.
Thanks
Cal .
-
Microsoft Corporation (MSFT $508.68)
-
Zoetis Inc. Class A (ZTS $120.12)
-
Novo Nordisk A/S (NVO $49.15)
Q: I am seeking single digit capital gain over the next 2 years which of the 3 companies would you buy. and why. what is the biggest risk for ZTS. is the competition from LLY now baked in to the price ofNVO thanks Richard
Q: I am interested in starting a position here. The recent acquisition they made should add to growth... unless it is not going well? Also I feel like I am motivated by its low price (opposite of momentum strategy). Any good news with the Q4 and LNTH should move higher. Your thoughts please.
Q: What is your current opinion of this stock..... do you think it will do well in the next 2 years?